Furthermore, agomelatine has demonstrated antioxidant properties via the Nrf2/HO-1 pathway in various pathological conditions, such as acute pancreatitis, cerebral ischemia, lung injury, and neuropathic pain [95,96,97,98]. This evidence concerns the gene NFE2L2 and acute pancreatitis.